Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study.
Mussini C, Cozzi-Lepri A, Meschiari M, Franceschini E, Burastero G, Faltoni M, Franceschi G, Iadisernia V, Volpi S, Dessilani A, Gozzi L, Conti J, Del Monte M, Milic J, Borghi V, Tonelli R, Brugioni L, Romagnoli E, Pietrangelo A, Corradini E, Girardis M, Busani S, Cossarizza A, Clini E, Guaraldi G.
Mussini C, et al. Among authors: conti j.
Viruses. 2023 Jan 20;15(2):294. doi: 10.3390/v15020294.
Viruses. 2023.
PMID: 36851508
Free PMC article.